Skip to main content

Table 1 Study schedule of specific assessments

From: Effect of YuPingFeng granules on clinical symptoms of stable COPD: study protocol for a multicenter, double-blind, and randomized controlled trial

 

Enrolment

(Day -28 to 0)

Follow-up(± 3 days) a

Visit period

Screening stage c

Visit 0

Visit 1

Visit 2

Visit 3

Visit 4

Visit 5

Additional visit b

 Visit time

Day -28 to 0

day 0

week 4

Week 12

Week 24

Week 36

Week 52

Basic condition

  Signing informed consent

       

  Demographic information d

       

 General clinical information e

       

Efficacy assessments

 SGRQ scale

 

 CAT scale

 

 Symptom scale

 Number of exacerbations and duration

  

 Number of hospitalizations and reasons

  

 Constitution of TCMf

 

  

 

 

Safety assessments

 Vital sign

 Physical examination

 

 HCG

       

 Glycosylated Hemoglobin

       

 Lung function

       

 Blood routine

   

 

 

 NGHX

   

 

 

 Serum biochemicals

   

 

 

 Adverse events recorded

 

Exploratory assessments g

 Microecology of the respiratory tract

 

 Herpesvirus infection

 

 Classification and counting of lymphocytes

 

 Inflammatory cytokines

 

 Immunoglobulin

 

Others

 Starting time of treatment

 

      

 Combination therapy

 

 Issue medications and diary cards

 

  

 Recycle medications and diary cards

  

 

 eCRF

  1. SGRQ The St George's Respiratory Questionnaire, CAT COPD assessment test, HCG Human chorionic gonadotropin, NGHX Urine dry chemical analysis, eCRF Electronic case report form
  2. aThe time window of follow-up is ± 3 days, while the additional visit is ± 1 day;
  3. bFor additional visits, if subjects have an acute exacerbation, an additional visit will be taken on the first day of the exacerbation;
  4. cThe time window of screening is -28 ~ 0 days, and Day 0 is the day on which medication is started. During the screening period, the results of HCG, GHb, NGHX, lung function, blood routine, and serum biochemicals can be accepted within 7 days;
  5. dDemographics, including age, gender, height, weight, marital status, ethnic origin, etc.;
  6. eGeneral clinical information, including medical history, course of the disease, number of exacerbations within the past year, etc.,
  7. fConstitution of TCM [23]: based on the Classification and Determination of Constitution in TCM(ZYYXH/T157-2009) released by the China Association of Chinese Medicine;
  8. gFor the exploratory assessments, the chief unit is required to conduct tests every visit, while others are required on Day 0, Week 24, Week 52, and additional visits. Sputum, throat swabs, and blood samples are detected and analyzed by the central laboratory and the results are uniformly recorded, but not included in the CRF